Having trouble viewing this email? View it as a Web page. You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).
12/22/2020 05:00 PM EST Experimental monoclonal antibody not efficacious in Phase 3 trial. |
Tuesday, December 22, 2020
Results of NIH-sponsored ACTIV-3 trial published
Subscribe to:
Post Comments (Atom)
MUST-SEE: Everyone will be talking about this $2 trillion AI tech boom soon
Amazon's secret move just sparked a projected... ...
-
insidecroydon posted: " Become a Patron! What's on inside Croydon: Click here for the latest events listing...
No comments:
Post a Comment